Identification of protein expression alterations in gefitinib-resistant human lung adenocarcinoma: PCNT and mPR play key roles in the development of gefitinib-associated resistance
- 1 November 2015
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 288 (3) , 359-373
Abstract
No abstract availableKeywords
Funding Information
- National Science Council Taiwan (101-2311-B-007-011, 102-2627-B-007-002, 102-2311-B-007-009, 103-2311-B-007-008)
- National Tsing Hua University (101N2725E1, 101N2771E1, 101N2051E1, 102N2048E1, 102N2759E1)
This publication has 22 references indexed in Scilit:
- Nuclear Proteomics with XRCC3 Knockdown to Reveal the Development of Doxorubicin-Resistant Uterine CancerToxicological Sciences, 2014
- Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6PLOS ONE, 2014
- Short-Course Treatment With Gefitinib Enhances Curative Potential of Radiation Therapy in a Mouse Model of Human Non-Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- 5-Methoxytryptophan-dependent protection of cardiomyocytes from heart ischemia reperfusion injuryArchives of Biochemistry and Biophysics, 2014
- Lung tumor growth-promoting function of peroxiredoxin 6Free Radical Biology and Medicine, 2013
- High glucose-induced proteome alterations in retinal pigmented epithelium cells and its possible relevance to diabetic retinopathyMolecular BioSystems, 2012
- Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cellsJournal of Proteomics, 2012
- Plasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysisMolecular BioSystems, 2011
- Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidenceLung Cancer, 2011
- The Role of Gefitinib in Lung Cancer TreatmentClinical Cancer Research, 2004